Understanding women’s motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence

BACKGROUND: In biomedical prevention trials, correct and consistent use of the investigational product is crucial to determine efficacy. Product adherence in VOICE, a phase 2B randomized trial of a vaginal gel and oral tablets for HIV prevention, was low (~ 34%), yet self-reported adherence and rete...

Descripción completa

Detalles Bibliográficos
Autores principales: Katz, Ariana W. K., Mensch, Barbara S., Woeber, Kubashni, Musara, Petina, Etima, Juliane, van der Straten, Ariane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347781/
https://www.ncbi.nlm.nih.gov/pubmed/30683103
http://dx.doi.org/10.1186/s12905-019-0713-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347781/
https://www.ncbi.nlm.nih.gov/pubmed/30683103
http://dx.doi.org/10.1186/s12905-019-0713-6

Ejemplares similares